Seed Round Led by Salesforce Ventures and Accel, with participation from Together Fund to Power Global Expansion SURAT, India , Sept. 23, 2025 /PRNewswire/ -- Rocket, the AI-powered app-building ...
Rocket Pharmaceuticals has withdrawn its application seeking Food and Drug Administration approval of its RP-L102 proposed gene therapy for the treatment of the rare, inherited blood disorder Fanconi ...
Shares of Rocket Pharmaceuticals surged after the Food and Drug Administration accepted its resubmitted application for its Kresladi drug to treat severe Leukocyte Adhesion Deficiency-I, a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results